The Food and Drug Administration shouldn’t be in the news if it’s doing its job right. By that measure the FDA is failing in spectacular fashion. The agency this week is making news for all of the ...

Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.

The Food and Drug Administration shouldn’t be in the news if it’s doing its job right. By that measure the FDA is failing in ...

The US FDA has tightened the use of a Duchenne muscular dystrophy gene therapy after two teenage patients died from acute ...

RELATED: San Antonio family raises awareness, funds for baby diagnosed with ultra-rare disease Sunday they held “Hope for ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

Beyond a cancer cell’s genetic blueprint, the expression levels of certain proteins on its surface is emerging as a collection of critical, actionable biomarkers. Instead of looking for a mutated gene ...

Women have risk factors such as genetics, hormones, and sex-specific responses to stress.

TuHURA Biosciences faces high investment risk amid cash shortages, dilution threats, and distant trial results. Click to read ...